Alkermes is seeking a strategic and execution-oriented Associate Director, HCP Marketing as a key member of the LUMRYZ marketing team. This individual will drive HCP launch readiness for the anticipated Idiopathic Hypersomnia (IH) indication for LUMRYZ targeted for 2028, while partnering with the narcolepsy HCP marketing team to support continued growth with the narcolepsy indication.
This role will help shape IH HCP strategy and launch readiness plans, build disease state/branded messaging and tactics, digital strategy, and support narcolepsy HCP digital execution. The ideal candidate brings strong HCP marketing experience, launch exposure, and experience operating in specialty and/or rare disease markets.
Alkermes has a hybrid working environment to support and meet the needs of employees and this role will operate in a flexible environment with 60% of time in the office and 40% from home. This role is not eligible for fully remote.
ResponsibilitiesKey Responsibilities:
Drive key components of HCP commercialization strategy and launch readiness planning for IH
Contribute to shaping HCP segmentation, campaign, messaging, across disease state and branded education initiatives for IH with narcolepsy indication in mind
Lead development of HCP promotional materials and digital strategy including website, CRM-based communications, email journeys, and targeted HCP media
Ensure patient journey and perspective is infused into HCP team strategies
Partner with Sales, Data, Analytics, & Insights, Market Access, Commercial Operations, and Patient Marketing to ensure aligned strategy and pull through
Translate customer insights, competitive intelligence, and market dynamics into actionable recommendations
Craft actionable assignment briefs for creative agencies
Collaborate with agency partners and internal stakeholders to deliver high-quality execution
Partner with analytics to monitor performance and optimize HCP engagement based on campaign insights
Guide branded and unbranded assets through the Medical, Legal and Regulatory review and approval process
Support HCP digital marketing tactics for the narcolepsy indication as needed
Minimum Education & Experience Requirements:
- Bachelor’s degree in marketing, business, science, or related field (MBA or advanced degree preferred)
- 10+ years of pharmaceutical, biotech, or healthcare marketing experience
Preferred Skills and Knowledge Qualifications:
- 3+ years of HCP marketing experience
- Launch or launch prep experience
- Rare disease and/or specialty market experience
- Experience in neurology, CNS, or sleep medicine
- Strong understanding of HCP engagement strategy and pharmaceutical promotion
- Experience supporting digital HCP engagement initiatives and field promotion
- Strong strategic thinking, communication, and analytical skills
- Ability to operate effectively in fast-paced, matrixed organizations
- Collaborative, proactive, and execution-oriented mindset
- Translate brand strategy into actionable tactical plans and execution
- Demonstrated success managing agencies and media partners
Travel Requirements:
- Overnight travel 30%
The annual base salary for this position ranges from $165k to $190k. In addition, this position is eligible for an annual performance pay bonus. Exact compensation may vary based on skills, training, knowledge, and experience. Alkermes offers a competitive benefits package. Additional details can be found on our careers website: www.alkermes.com/careers#working-here
#LI-TT1 #LI-hybrid
About UsWhy join Team Alkermes?
Alkermes applies its decades of deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. A global biopharmaceutical company, headquartered in Ireland with U.S. locations in Massachusetts and Ohio, we seek to make a meaningful difference in the way people manage their diseases. We have a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder and narcolepsy, and a pipeline of clinical and preclinical candidates in development for various psychiatric and neurological disorders.
We are proud to have been recognized as an employer of choice by many national organizations. In 2024 and 2025, we were certified as a Great Place to Work in the U.S. and named one of Massachusetts’ Top Places to Work by the Boston Globe, a Best Place to Work in Greater Cincinnati by the Cincinnati Business Courier and recognized as a Best Place to Work in BioPharma by Fortune Magazine.
Alkermes, Inc. is an equal employment opportunity employer and does not discriminate against any qualified applicant or employee because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, gender expression and identity, disability, genetic information, veteran status, military status, application for military service or any other characteristic protected by local, state or federal law. Alkermes also complies with all work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Alkermes is an E-Verify employer.
Alkermes Waltham, Massachusetts, USA Office
852 Winter Street, Waltham, MA 02451, US, Waltham, MA, United States, 02451
Similar Jobs
What you need to know about the Boston Tech Scene
Key Facts About Boston Tech
- Number of Tech Workers: 269,000; 9.4% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Thermo Fisher Scientific, Toast, Klaviyo, HubSpot, DraftKings
- Key Industries: Artificial intelligence, biotechnology, robotics, software, aerospace
- Funding Landscape: $15.7 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Summit Partners, Volition Capital, Bain Capital Ventures, MassVentures, Highland Capital Partners
- Research Centers and Universities: MIT, Harvard University, Boston College, Tufts University, Boston University, Northeastern University, Smithsonian Astrophysical Observatory, National Bureau of Economic Research, Broad Institute, Lowell Center for Space Science & Technology, National Emerging Infectious Diseases Laboratories
